As digital health innovation continues to accelerate, more companies are developing software that supports clinical decision-making, patient monitoring and healthcare delivery. While many focus on building innovative products and securing investment, regulatory requirements are often considered much later in the journey.

That can be an expensive mistake.

At GIANT Health, we're proud to work alongside organisations that help innovators bring safe, compliant healthcare technologies to market. One of those partners is LFH Regulatory, a specialist consultancy supporting digital health companies through the complex regulatory landscape for Software as a Medical Device (SaMD).

Why Regulation Should Be Considered from Day One

Many digital health companies begin with an app, software platform or AI solution designed to solve a healthcare challenge. However, not every product creator realises that their software may fall under medical device regulations.

According to LFH Regulatory, one of the first questions every digital health company should ask is:

Is our software actually a medical device?

The answer depends on the product's intended purpose and how it supports diagnosis, monitoring, prediction, treatment or other medical functions—not simply because it is used in a healthcare setting. A proper assessment should consider the software's functionality, intended users, outputs and how healthcare professionals rely on its results.

Building a Regulatory Strategy

Once software is determined to be a medical device, companies should identify the appropriate classification, define their priority markets and understand the regulatory pathway before making commercial commitments.

Early planning helps organisations:

• Develop a realistic route to market

• Align product claims with available evidence

• Avoid unnecessary delays

• Reduce costly redevelopment later in the product lifecycle

LFH Regulatory emphasises that regulatory strategy should support commercial strategy—not slow it down.

Integrating Compliance into Product Development

Rather than treating compliance as a final hurdle before launch, LFH recommends embedding regulatory requirements into software development from the beginning.

This includes:

• Software lifecycle planning

• Risk management

• Verification and validation

• Cybersecurity planning

• Usability engineering

• Documentation and traceability

By integrating these activities throughout development, companies can create stronger evidence while avoiding significant retrospective work.

Preparing for Long-Term Success

Medical device software continues to evolve after launch. Software updates, cybersecurity improvements and post-market surveillance all require structured processes to ensure products remain safe, effective and compliant.

Planning these activities early allows companies to scale confidently while meeting regulatory expectations.

About LFH Regulatory

LFH Regulatory supports software and digital health companies in determining whether their products qualify as medical devices and establishing practical routes to market. Their expertise includes Software as a Medical Device (SaMD), regulatory strategy, quality management systems, software lifecycle documentation, risk management, clinical evidence and post-market planning.

To learn more about LFH Regulatory and their regulatory services, visit their website or connect with their team.

Meet LFH Regulatory at GIANT Health

GIANT Health brings together the organisations helping shape the future of healthcare innovation—from NHS leaders and investors to pioneering health technology companies and regulatory experts.

If you're developing digital health solutions and looking to accelerate your route to market, keep an eye out for LFH Regulatory at future GIANT Health events and discover how expert regulatory guidance can support your innovation journey.

This article highlights key insights from LFH's guidance on Software as a Medical Device (SaMD). To read the full article and explore more regulatory resources, visit the original article on the LFH website.